632978559 | PUO | 30760602 | | 4777381 | 5/30/2006 12:00:00 AM | CHF exacerbation | | DIS | Admission Date: 5/28/2006 Report Status: Discharge Date: 8/13/2006 ****** FINAL DISCHARGE ORDERS ****** MERRELL , VICENTA 523-62-97-7 Jose Service: CAR DISCHARGE PATIENT ON: 8/27/06 AT 03:00 PM CONTINGENT UPON HO evaluation WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES Attending: PREWER , FERNANDE RANDY , M.D. CODE STATUS: Full code DISPOSITION: Home w/ services DISCHARGE MEDICATIONS: ECASA 81 MG PO DAILY Starting Today ( 6/28 ) Override Notice: Override added on 4/24/06 by GUSMAR , GAYE , M.D. on order for COUMADIN PO ( ref # 973318561 ) POTENTIALLY SERIOUS INTERACTION: ASPIRIN &amp; WARFARIN Reason for override: ok LIPITOR ( ATORVASTATIN ) 40 MG PO BEDTIME Alert overridden: Override added on 8/27/06 by : POTENTIALLY SERIOUS INTERACTION: ERYTHROMYCIN &amp; ATORVASTATIN CALCIUM Reason for override: home DIGOXIN 0.25 MG PO DAILY Starting Today ( 6/28 ) Override Notice: Override added on 4/24/06 by GUSMAR , GAYE , M.D. on order for ERYTHROMYCIN OPHTHALMIC OINTMENT OU ( ref # 256680077 ) SERIOUS INTERACTION: DIGOXIN &amp; ERYTHROMYCIN Reason for override: ok LASIX ( FUROSEMIDE ) 80 MG PO DAILY Starting IN AM ( 6/28 ) INSULIN NPH HUMAN 40 UNITS QAM; 30 UNITS QPM SC 40 UNITS QAM 30 UNITS QPM IMDUR ER ( ISOSORBIDE MONONITRATE ( SR ) ) 30 MG PO DAILY Food/Drug Interaction Instruction Give on an empty stomach ( give 1hr before or 2hr after food ) LISINOPRIL 10 MG PO DAILY Alert overridden: Override added on 8/27/06 by : POTENTIALLY SERIOUS INTERACTION: SPIRONOLACTONE &amp; LISINOPRIL POTENTIALLY SERIOUS INTERACTION: POTASSIUM CHLORIDE &amp; LISINOPRIL POTENTIALLY SERIOUS INTERACTION: POTASSIUM CHLORIDE &amp; LISINOPRIL Reason for override: MD aware TOPROL XL ( METOPROLOL SUCCINATE EXTENDED RELEASE ) 25 MG PO DAILY Starting IN AM ( 6/28 ) Food/Drug Interaction Instruction Take consistently with meals or on empty stomach. 
Number of Doses Required ( approximate ): 1 ALDACTONE ( SPIRONOLACTONE ) 12.5 MG PO DAILY Food/Drug Interaction Instruction Give with meals Override Notice: Override added on 3/8/06 by ECKLER , ROLANDA , M.D. on order for LISINOPRIL PO 10 MG QD ( ref # 722939611 ) POTENTIALLY SERIOUS INTERACTION: SPIRONOLACTONE &amp; LISINOPRIL Reason for override: aware Previous override information: Override added on 4/24/06 by GUSMAR , GAYE , M.D. POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; SPIRONOLACTONE SERIOUS INTERACTION: POTASSIUM CHLORIDE &amp; SPIRONOLACTONE Reason for override: ok DIET: Fluid restriction DIET: House / Low chol/low sat. 
fat DIET: House / ADA 1800 cals/dy ACTIVITY: Resume regular exercise FOLLOW UP APPOINTMENT( S ): Dr. Mathew Stautz ( PUO Cardiology ) 1/21/06 at 4:40 pm scheduled , Dr. Tarsha Prall ( PCP ) to be seen in next 2 weeks , Totin Hospital And Clinic Endocrinology -you will be contacted on monday 4/12 for an appointmen , ALLERGY: Penicillins ADMIT DIAGNOSIS: CHF exacerbation PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission ) CHF exacerbation OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay CARDIOMYOPATHY-EF 35% , ASTHMA , CAD , HTN , hx ETOH ABUSE , INSULIN REQ TYPE II DM OPERATIONS AND PROCEDURES: 8/6 Left Heart Catherization 9/29 Right Heart Catherization Please see hospital course for salient details. 
OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. ) none BRIEF RESUME OF HOSPITAL COURSE: **CC / ADMIT Dx: SOB **BRIEF HPI: 45M with non-DCM ( EF25% ) , DM2 , HTN p/w CHF exacerbation / hypoxia ( PND , dyspnea , cough , ?chest tightness on AM of admit ) likely 2/2 to dietary indiscretion and medical noncompliance. 
Treated with lasix , aldactone , ACE , with improvement from NRB to 2L by NC. **RELEVANT PMHX: -DCM ( EtOH ) EF 20-25% ( 5/27 ) followed by Dr. Mathew Stautz s/p angiography 1995 with 50% LAD ( no intervention ) -HTN -DMII -OSA on CPAP -Asthma **ALLERGIES: PCN ( rash ) **HOME MEDS: Lipitor 20 , Dig 0.l25 , ASA , Lasix 80 , Glipizide 5 , Metformin 500 TID , Insulin 70/30 40 QAM/30 QPM , Lisinopril 10 , Toprol 25 , Aldaction 25 , Coumadin 5 **DAILY STATUS/EXAM: VS 5/14 AF , P70-100 , BP90-110/60-70 , O2 94 on RA PULM: CTA CV: JVP 8 , distant , RRR , no murmurs noted ABD: S/NT/ND EXTR: 1+ edema to mid-calf bilat , warm , 2+ pulses NEURO: AOx3 , non-focal **TESTS/PROCEDURES: 8/6 LHC showed worsening 3vd from prior , no intervention RHC releaved elevated left and right filling pressures , no transpulmonary gradient. 
**CONSULTS: ACE , SS , nutrition **Hospital Course: CV/I: Patient was sucessfully ruled out by serial enzymes for a potential myocardial infarction. 
The patient was continuedon his home ASA , statin , and BB during his hospital course. 
To rule out concern for ischemia as a role in the deterioration of his cardiomyopathy , a left heart catheterization was performed which showed worsening CAD from his prior study 5 years. 
The patient has 3vd disease with diffuse lesions in his RT PDA , RT LV-VR , LAD , Lcx. 
Given the patient's symptoms and echocardiographic evidence of cardiomyopathy proceeded the progression of his CAD , it is likely that his arteriosclerosis was not the primary etiology of his imparied cardiac performance though may be contributing to his disease at this time. 
CV/P: CXR on admission revealed pulmonary edema. 
The patient had an excellent reponse to diuresis on lasix and was weaned to room air on the day after admission. 
His home blood pressure medications were continued , and were well controlled. 
A right heart catheterization was performed on 6/3 which showed elevated right and left sided filling pressures , particularly with a Pcw of 24 and mean RA pressure of 5. The patient was started on Imdur during this admission. 
His lisinopril was continued. 
Pt CV/R: Patient is undergoing evaulation for ICD. 
NO ectopy was noted during full-time telemetric monitoring. 
PULM: His OSA was treated with CPAP at 6 cm. 
No active asthma rx. 
No wheezes on exam. 
ENDO: Patient was maintained off his oral medications and placed on insulin alone. 
On admission , his blood sugars were in the 300s. 
His Last A1C was found to be 9.5. 
While following his blood sugars , his insulin was titrated up and drug therapy discontinued. 
He was discharged with BID NPH insulin to replace his previous med/insulin regimen. 
PUO outpatient diabetes services follow-up will be arranged for the patient. 
HEME: On coumadin with admit INR 1.1. 
Coumadin was held during admission and patient instructed to discontinue medication as outpatient considering no hx of afib , LV throbus , or DVT/clot as well as questions with medication compliance. 
F/E/N: Patient was instructed on proper diabetic and HF diet. 
PSYCH/SOCIAL: Hx EtOH abuse , last drink day of admit. 
LFTs were unremarkable. 
Patient also lives with cocaine-using brother hough pt denies use. 
UTox was negative. 
GRH consult provided listing of japanese AA meetings. 
Social work helped arranged a medical bed for patient at home , and to facilitate his ability to obtain public housing. 
The patient was discharged home in stable condition. 
Followup appts were arranged with his cardiologist , Dr. Raisa Cervetti Also , outpatient diabetes management followup will be arranged with the patient by the PUO Endocrine service. 
He was also instructed to make an appt with his PCP within two weeks. 
VNA services have been obtained to teach and assist him in this new medication changes.. ADDITIONAL COMMENTS: STOP taking your coumadin. 
STOP taking your metformin and gliburide. 
CHANGE your insulin to NPH insulin 40 units in the morning and 30 units before bedtime. 
DISCHARGE CONDITION: Stable TO DO/PLAN: follow-up with your cardiologist as instructed. 
No dictated summary ENTERED BY: ECKLER , ROLANDA , M.D. ( FY73 ) 8/27/06 @ 02 ****** END OF DISCHARGE ORDERS ******